Zimmer Biomet (ZBH) Holdings announced it has completed the acquisition of Monogram Technologies (MGRM). With the acquisition complete, Monogram shares ceased trading on the National Association of Securities Dealers Automated Quotations prior to the opening of the market on October 7, 2025, and will be delisted.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet’s Innovative Hip System Gains Approval in Japan, But Hold Rating Maintained Amid Uncertainty
- Zimmer Biomet’s hip replacement system approved by Japan’s PMDA
- Zimmer Biomet price target raised to $118 from $115 at Stifel
- Target initiated, Nike upgraded: Wall Street’s top analyst calls
- Zimmer Biomet initiated with a Buy at Rothschild & Co Redburn